Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer.
Sci Rep
; 11(1): 24423, 2021 Dec 20.
Article
in En
| MEDLINE
| ID: mdl-34931014
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Sci Rep
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido